Cydar Maps Planning and Navigation Solution Expanded to Enable Use in Complex Branched and Visceral Cases

April 29, 2026—Cydar Medical, a developer of cloud-based artificial intelligence solutions for endovascular surgery, announced an expanded release of Cydar Maps.

Cagent Vascular’s Serranator PTA Device Studied for Pedal Interventions in Patients With CLTI

April 29, 2026—Cagent Vascular announced the publication of data demonstrating the safety and efficacy of the company’s Serranator percutaneous transluminal angioplasty (PTA) serration balloon catheter in pedal (inframalleolar) interventions for patients with chronic limb-threatening ischemia (CLTI).

Concept Medical’s MagicTouch PTA in Femoropopliteal Disease Evaluated at 3 Years in SIRONA Trial

April 29, 2026—Concept Medical Inc. announced preliminary 3-year follow-up data from the SIRONA randomized trial comparing the company’s MagicTouch PTA device, a sirolimus-coated balloon for percutaneous transluminal angioplasty (PTA), versus paclitaxel-coated balloon angioplasty in femoropopliteal artery disease.

Hjarta Care’s EVAR XplantR for Aortic Endograft Explantation Receives FDA De Novo Authorization

April 29, 2026—Hjarta Care announced that the FDA has granted de novo authorization for the EVAR XplantR, which is a purpose-built, single-use device designed for the safe and efficient explantation of aortic endografts used in endovascular aortic repair (EVAR).

Reva Medical’s MOTIV BTK Trial Meets Primary Efficacy Endpoint

April 29, 2026—Reva Medical, LLC announced primary endpoint results from the pivotal MOTIV BTK randomized clinical trial evaluating the safety and efficacy of the company’s Motiv sirolimus-eluting bioresorbable vascular scaffold in patients with infrapopliteal arterial disease.

Angiolutions Appoints International Endovascular Experts to Its Medical Board

April 29, 2026—Angiolutions announced the appointment of four internationally recognized vascular and endovascular specialists to its Medical Board, which will support the company as it advances development of the investigational A3-Shield system.

Vena MicroAngioscope System Used in First Commercial Cases in the United States

April 28, 2026—Vena Medical, a Kitchener, Canada—based developer of direct intravascular imaging systems, announced completion of the first commercial cases in the United States with the Vena MicroAngioscope system.

RODEO-PTAB Evaluates Single-Vessel Runoff in SFA Disease Treated With Endologix Detour System

April 28, 2026—Recent findings from a substudy of DETOUR2 demonstrated that percutaneous transmural arterial bypass (PTAB) may offer an alternative to leg bypass surgery for patients with complex peripheral arterial disease, even when distal vessel run off is severely limited.